Delivery Order SPE2DB22D2005-SPE2DB26FJEM8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,742.45. This competitively awarded, non-set-aside contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025, and reflects a firm fixed price arrangement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $7,010.69 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) with an ultimate completion date of September 4, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,866.60 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of April 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,551.14 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The contract, awarded on June 11, 2025, with an ultimate completion date of June 12, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, serving as the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S under a firm fixed-price contract valued at $4,928.37, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product, on June 20, 2025. The contract is valued at $1,945.40 with a firm fixed price structure and an ultimate completion date of June 23, 2025. This non-set-aside award represents a competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,726.30 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of September 8, 2025. This non-competitive, firm fixed-price delivery order was issued on September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.04 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lidocaine 5% Patch 30s. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is expected to be completed by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,772.64 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,297.25 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lidocaine 5% Patch 30s. This competitively awarded contract, utilizing firm fixed pricing with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJEM8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,542.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain relief medication. The contract is a firm fixed price delivery order with no set-aside designation, issued competitively on October 24, 2025, with an ultimate completion date of October 27, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this prime contract vehicle, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/24/25 |